PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
PanTRKare™ Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib)
NANJING, China , Aug. 12, 2026 /PRNewswire/ -- August 6,  the NMPA granted approval to Geneseeq's PanTRKare™ NTRK1/2/3 Gene Fusion Detection Kit as a companion diagnostic for VELMARTO ® ...
2026-08-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
RingConn Advances Wearable Health Research with New Study in Nature Portfolio Journal npj Digital Medicine
The study, "Large-scale bilateral cardiovascular monitoring via wearable rings," analyzes 97,559 valid ring-PPG samples from 1,810 participants, providing new insights into bilateral wearable ...
2026-08-12T    Computer/Electronics   Consumer Electronics   Health Care/Hospital   Medical Equipment 
Insilico Medicine Nominates ISM0900, a Potent, AI-driven, Oral Lp(a) Inhibitor, as PCC for Management of Cardiovascular Risks
CAMBRIDGE, Mass. , Aug. 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company , today ...
2026-08-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Beyang Closes Oversubscribed $30 Million Series A Financing
Funding to accelerate the iteration of the proprietary AI-driven ExCEED platform and advance global clinical development of differentiated pipelines, including a second-generation Menin inhibitor ...
2026-08-12T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Beyang Closes Oversubscribed $30 Million Series A Financing
Funding to accelerate the iteration of the proprietary AI-driven ExCEED platform and advance global clinical development of differentiated pipelines, including a second-generation Menin inhibitor ...
2026-08-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
SingHealth Launches Global Network for World-Class Healthcare Administrator Immersion and Development
SingHealth is working alongside nine leading academic medical centres and health systems worldwide to formalise a structured exchange programme for healthcare administrators. Administrators will ...
2026-08-12T    Health Care/Hospital   Trade show news 
Senhwa's CX-5461 Opens a New Frontier in Photoimmunotherapy; Multinational Study Published in Nucleic Acids Research
TAIPEI and SAN DIEGO , Aug. 12, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. ( TPEx : 6492) today announced a significant research advance involving its investigational drug Pidnarulex (CX-5461). ...
2026-08-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Helfie AI Appoints Heavyweight Tech and Governance Leaders to its Board of Directors
Former Apple and Airbnb executive Patrick Gates and ex-Meta executive Sunita Parasuraman join as Non-Executive Directors, strengthening Helfie's technology and governance. ...
2026-08-12T    Computer/Electronics   Health Care/Hospital 
New Drug Application for LAE002 (afuresertib) Accepted by China's National Medical Products Administration
SHANGHAI , Aug. 12, 2026 /PRNewswire/ -- Laekna (2105.HK) announced today that the New Drug Application (NDA) for LAE002 (afuresertib) has been accepted by the Center for Drug Evaluation (CDE) of China's ...
2026-08-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Datasea Announces FDA Registration and Device Listing for NeuroVibe Acoustic BCI Biofeedback System as a Class II 510(k)-Exempt Biofeedback Medical Device
BEIJING , Aug. 11, 2026 /PRNewswire/ -- Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company focused on acoustic high-tech and AI ...
2026-08-11T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.